Serum Exosomal Proteins F9 and TSP-1 as Potential Diagnostic Biomarkers for Newly Diagnosed Epilepsy

Zijun Lin,Yixue Gu,Ruijiao Zhou,Meiling Wang,Yi Guo,Yuanyuan Chen,Junhong Ma,Fei Xiao,Xuefeng Wang,Xin Tian
DOI: https://doi.org/10.3389/fnins.2020.00737
IF: 4.3
2020-08-04
Frontiers in Neuroscience
Abstract:Epilepsy is one of the most common chronic neurological diseases in the world, with a high incidence, a high risk of sudden unexplained death, and diagnostic challenges. Exosomes are nanosized extracellular vesicles that are released into physical environments and carry a variety of biological information. Moreover, exosomes can also be synthesized and released from brain cells, passing through the blood-brain barrier, and can be detected in peripheral blood or cerebrospinal fluid. Our study using the tandem mass tag (TMT) approach showed that a total of 76 proteins were differentially expressed in serum exosomes between epilepsy patients and healthy controls, with 6 proteins increasing and 70 proteins decreasing. Analysis of large clinical samples and two mouse models of chronic epilepsy indicated that two significantly differentially expressed serum exosomal proteins, coagulation factor IX (F9) and thrombospondin-1 (TSP-1), represent promising biomarkers for the diagnosis of epilepsy, with area under the curve (AUC) values of up to 0.7776 (95% CI, 0.7306–0.8246) and 0.8534 (95% CI, 0.8152–0.8916), respectively. This is the first study of exosomal proteins in epilepsy, and it suggests that exosomes are promising new tools for the diagnosis of epilepsy.
neurosciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **Finding effective biomarkers for newly - diagnosed epilepsy**. Specifically, the author aims to identify potential biomarkers that can be used for epilepsy diagnosis by studying the differential expression of serum exosome proteins between epilepsy patients and healthy controls. ### Background and the Importance of the Problem 1. **High Incidence of Epilepsy and Diagnostic Challenges** - Epilepsy is one of the most common chronic neurological diseases in the world. There are approximately 50 million people with epilepsy globally, and about 2.4 million new cases are added each year. - The risk of early death in epilepsy patients is significantly higher than that in the general population, and about 180,000 people die from epilepsy each year. - The diagnosis of epilepsy is challenging. Approximately 25% of patients are misdiagnosed as having epilepsy, and the diagnostic value of traditional diagnostic methods such as EEG (electroencephalogram) in professional epilepsy monitoring units is still limited. 2. **Limitations of Existing Treatments** - Although early antiepileptic drugs (AED) can effectively reduce the risk of epileptic seizures in the short term, about 30% of patients still cannot control epileptic seizures through drugs, and drug side effects are frequent. ### Specific Objectives of the Research To address the above challenges, the objectives of this research are: - **Identifying New Biomarkers**: By analyzing the differential expression of serum exosome proteins, find molecular markers that can quickly, economically, and non - invasively assist in the diagnosis of epilepsy. - **Verifying the Diagnostic Value of Potential Markers**: Use large - scale clinical samples and animal models to verify whether the differentially expressed proteins found can be used as reliable diagnostic tools. ### Main Findings Through proteomic analysis of serum exosomes from 200 newly - diagnosed epilepsy patients and 200 healthy controls, the authors found: - **76 Differentially Expressed Proteins**: Among them, the expression of 6 proteins increased, and the expression of 70 proteins decreased. - **Two Significantly Differentially Expressed Proteins**: Coagulation factor IX (F9) and thrombospondin 1 (TSP - 1), which showed significant up - regulation and down - regulation respectively. - **Diagnostic Value Evaluation**: Through receiver operating characteristic curve (ROC) analysis, the areas under the curve (AUC) of F9 and TSP - 1 were 0.7776 and 0.8534 respectively, indicating that these two proteins have high diagnostic value. ### Conclusions This study reveals for the first time the potential of exosome proteins in epilepsy diagnosis. In particular, F9 and TSP - 1 may become effective biomarkers for newly - diagnosed epilepsy. This provides an important scientific basis for the development of more accurate and convenient epilepsy diagnosis methods in the future. --- If you need to further understand the specific experimental methods or data analysis of the study, please let me know, and I will continue to interpret it in detail for you.